Skip to content

Frontlight ResearchEarly access

Trial site

Instituto Clinico del Sur. ICOS (Site 0290)

Temuco, Araucania 4810469, ChileNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Gastric and oesophageal cancer

Closed trials

Completed
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)
NCT03221426· Phase 3· Merck Sharp & Dohme LLC· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Instituto Clinico del Sur. ICOS (Site 0290): trial site – Frontlight Research